AMERICAN GENCARE GROUP INC – Trademark Portfolio

Entity Type: 03

AMERICAN GENCARE GROUP INC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include VEV, COREFEEL, and DEEPCALM. The owner is based in SHERIDAN, WY.

30 N GOULD ST STE N

SHERIDAN, WY 82801

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UPMAG
UPMAG
Pending 2026
UPMAGO
UPMAGO
Pending 2026
COREFEEL
COREFEEL
Registered 2025
DEEPCALM
DEEPCALM
Registered 2025
VEV
VEV
Registered 2024
VEV
VEV
Registered 2021

Trademark Classifications

AMERICAN GENCARE GROUP INC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does AMERICAN GENCARE GROUP INC have?

AMERICAN GENCARE GROUP INC has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending.

What trademark classes does AMERICAN GENCARE GROUP INC file in?

AMERICAN GENCARE GROUP INC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AMERICAN GENCARE GROUP INC's most well-known trademarks?

AMERICAN GENCARE GROUP INC's registered trademark portfolio includes well-known marks such as VEV, COREFEEL, and DEEPCALM. These are among 4 currently registered trademarks in the portfolio.

What is AMERICAN GENCARE GROUP INC's trademark registration success rate?

AMERICAN GENCARE GROUP INC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 3 applications are pending review.